SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029397
Filing Date
2022-08-15
Accepted
2022-08-15 08:01:02
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20220630.htm   iXBRL 10-Q 1677601
2 EX-31.1 vcnx-ex311_13.htm EX-31.1 21872
3 EX-31.2 vcnx-ex312_12.htm EX-31.2 21785
4 EX-32.1 vcnx-ex321_11.htm EX-32.1 10852
  Complete submission text file 0001564590-22-029397.txt   5788477

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20220630.xsd EX-101.SCH 47049
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20220630_cal.xml EX-101.CAL 30633
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20220630_def.xml EX-101.DEF 138591
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20220630_lab.xml EX-101.LAB 351370
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20220630_pre.xml EX-101.PRE 257698
60 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-10q_20220630_htm.xml XML 874182
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 221162428
SIC: 2834 Pharmaceutical Preparations